No Prescription |
 |
 | ||
|
Eptus Inspra |
|
| ||
No Prescription » Prescription Drugs 7 » Eptus Inspra This medication is used alone or in combination with other medicines to treat high blood pressure. It works by blocking a chemical (aldosterone) in your body which in turn lowers the amount of sodium and water the body retains. Lowering high blood pressure helps prevent strokes heart attacks and kidney problems. It is also used to treat congestive heart failure following a heart attack.How to use Eptus OralTake this medication by mouth usually once or twice daily with or without food; or as directed by your doctor. The dosage is based on your medical condition (high blood pressure congestive heart failure) and response to therapy. Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time(s) each day.It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick.It may take up to 4 weeks for this medication to take full effect on your blood pressure.What conditions does this medication treat?Eptus Oral is used to treat the following:High Blood Pressure Heart Failure After a Heart AttackINSPRA Oral may also be used to treat:Chronic Heart Failure Buy Eptus Inspra and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Eptus Inspra: Product Type: Prescription Drugs 7 Eptus ( Inspra Generic Eplerenone ) Eptus (Inspra Generic Eplerenone) Inspra Generic Eplerenone 25mg 60(6 x 10) Tablets 25mg 90(9 x 10) Tablets 25mg 30(3 x 10) Tablets 50mg 90(9 x 10) Tablets 50mg 30 Tablets 50mg 60(6 x 10) Tablets Inspra Generic Eplerenone Eptus
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
